Iatrogenic Immunodeficiency–associated Polymorphic Lymphoproliferative Disorder Resulting in Complete Remission After Tacrolimus Withdrawal in Systemic Lupus Erythematosus: A Case Report
Clicks: 3
ID: 313414
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.6
/100
3 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #27 of 47 articles by views in Modern Rheumatology Case Reports
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
A 27-year-old woman was diagnosed with systemic lupus erythematosus and successfully achieved remission. She remained in long-term remission without relapse while receiving prednisolone, tacrolimus, and hydroxychloroquine. At the age of 42, after receiving an influenza vaccination, she developed multiple, progressively enlarging, painless cervical lymph nodes and was referred to our hospital. She presented with fever and cervical lymphadenopathy. Laboratory examination revealed an elevated sIL-2 receptor of 3300 U/mL. Computed tomography demonstrated lymphadenopathy in the left posterior cervical and left submandibular regions, as well as paraaortic lymphadenopathy. 18F-fluorodeoxyglucose positron emission tomography showed abnormal uptake with a maximum standardized uptake value of 14.5. A biopsy of the left posterior cervical lymph node was performed. Histopathological examination showed findings compatible with malignant lymphoma; however, definitive classification was difficult because immunohistochemistry showed loss of CD20 expression in the atypical cells and plasmacytic differentiation. In situ hybridization for Epstein-Barr virus-encoded RNA was negative. Based on the biopsy findings, we diagnosed the patient with Epstein-Barr virus-negative polymorphic lymphoproliferative disorder. We discontinued tacrolimus at the initial visit, after which the lymphadenopathy gradually regressed with almost complete resolution six months later. Iatrogenic immunodeficiency-associated polymorphic lymphoproliferative disorder resulting in complete remission after tacrolimus withdrawal in a patient with systemic lupus erythematosus has not been previously reported. Clinicians should be aware that iatrogenic immunodeficiency-associated polymorphic lymphoproliferative disorder may occur during tacrolimus use and that discontinuation of the drug may lead to improvement of lymphadenopathy.
| Reference Key |
openalex_W7161276301
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Misaki Yoshida, Ichiro Mizushima, Hiroko Ikeda, Akihiko Koshino, Keisuke Sako, Takahiro Yuasa, Shunsuke Tsuge, Taichiro Minami, Yuta Yamamura, Ryo Nishioka, Megumi Oshima, Satoshi Hara, Kiyoaki Ito, Norihiko Sakai, Miho Shimizu, Yasunori Iwata |
| Journal | Modern Rheumatology Case Reports |
| Year | 2026 |
| DOI |
10.1093/mrcr/rxag038
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.